HGH Fragment 176-191
Preclinical — Animal / cell-model data onlyWhat it is
A fragment of growth hormone marketed for fat loss without the full GH effects. Human evidence is weak.
HGH Fragment 176-191 is a fragment of growth hormone marketed for fat loss without the full GH effects, though the human evidence is weak.
Research context
Studied in relation to:
- Fat-metabolism research
Points in its favour in the literature:
- Marketed as targeted to fat metabolism
Caveats and unknowns:
- Human fat-loss evidence weak
- Unlicensed for human use
- Prohibited in sport
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature.
Published clinical / research context (not instructions)Reported research ~250–500 mcg, often 1–2× daily.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 5 mg vial + 2 mL → 2.5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 2mg | FR2 |
| 5mg | FR5 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.